Health Products

Riva-Quetiapine 200 mg

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety, Contamination
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
Bottle size: 100 tabs:
Recalling Firm
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
A. Riva-Quetiapine 200 mgTabletDIN 02316722200 mg / tablet

Introduction

Recalled products
  1. Riva-Quetiapine 200 mg

Reason

Potential cross-contamination of trace amounts of Clindamycin in Quetiapine Active Pharmaceutical Ingredient during the manufacturing process.

Depth of distribution

Wholesalers and pharmacies in Quebec, Ontario, and British-Columbia
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime